MedTrace Logo

Art Therapy Effectiveness in the Level of Anxiety and Depression of Cancer Patients

NCT04936139 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 224

Last updated 2024-02-05

No results posted yet for this study

Summary

Having a diagnosis of cancer leaves a great emotional impact when it comes to strategies for coping with illness and life after illness. Participation in an art therapy program to forge and improve the emotional well-being is considered.

Art therapy can be an effective intervention to help cancer patients lower their levels of anxiety and depression and in return improve their quality of life and their ability to cope with the disease.

Conditions

Interventions

BEHAVIORAL

Art Therapy

During the 12 planned sessions, different artistic disciplines will be used: visual arts, music, play, narrative, dramatization, movement and body expression. Each session is structured in 3 phases: i. A first part of encounter and contextualization, to make contact with oneself, with the art therapist and with the group through a relaxation or meditation activity (35 minutes). ii. A second part, where the session continues with the work of artistic elaboration and production with the different materials and the different artistic languages (50 minutes). iii. A third part where the participants will be invited to make a closing, a moment to welcome and share whoever wishes, the experiences that have been experienced. A dialogue is created between Work-Patient-Art Therapist (35 minutes).

Sponsors & Collaborators

  • Fundació privada Nous Cims

    collaborator UNKNOWN

  • Althaia Xarxa Assistencial Universitària de Manresa

    collaborator OTHER

  • Elisenda Campreciós Suñol

    lead OTHER

Principal Investigators

  • Pau Gomes, MsC · Fundació Nou Cims

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-21
Primary Completion
2023-11-03
Completion
2023-11-03

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04936139 on ClinicalTrials.gov